| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 肠胃康(元) | 112,864,037.68 | 162,201,935.07 | 71,143,586.75 |
| 头孢制剂系列(元) | 45,879,500.97 | 238,481,211.58 | 136,060,603.44 |
| 医疗服务费(元) | 83,732,699.22 | 168,331,131.57 | 77,230,860.34 |
| 原料药及中间体(元) | 59,740,525.96 | 148,841,602.60 | 114,558,870.07 |
| 医疗器械(元) | - | - | - |
| 其他(元) | 134,757,281.26 | 244,816,357.48 | 178,766,087.20 |
| 营业成本(元) | |||
| 肠胃康(元) | 27,141,235.27 | 36,651,720.11 | 13,875,461.87 |
| 头孢制剂系列(元) | 44,206,921.00 | 117,712,027.29 | 53,115,698.93 |
| 医疗服务费(元) | 74,481,542.30 | 140,197,354.40 | 67,408,412.69 |
| 原料药及中间体(元) | 57,160,386.72 | 146,076,034.57 | 103,607,979.95 |
| 医疗器械(元) | - | - | - |
| 其他(元) | 113,025,214.41 | 187,153,808.32 | 147,724,249.44 |
| 毛利(元) | |||
| 肠胃康(元) | 85,722,802.41 | 125,550,214.96 | 57,268,124.88 |
| 头孢制剂系列(元) | 1,672,579.97 | 120,769,184.29 | 82,944,904.51 |
| 医疗服务费(元) | 9,251,156.92 | 28,133,777.17 | 9,822,447.65 |
| 原料药及中间体(元) | 2,580,139.24 | 2,765,568.03 | 10,950,890.12 |
| 医疗器械(元) | - | - | - |
| 其他(元) | 21,732,066.85 | 57,662,549.16 | 31,041,837.76 |
| 毛利率(%) | |||
| 肠胃康(%) | 75.95 | 77.40 | 80.50 |
| 头孢制剂系列(%) | 3.65 | 50.64 | 60.96 |
| 医疗服务费(%) | 11.05 | 16.71 | 12.72 |
| 原料药及中间体(%) | 4.32 | 1.86 | 9.56 |
| 医疗器械(%) | - | - | - |
| 其他(%) | 16.13 | 23.55 | 17.36 |
| 收入构成(%) | |||
| 肠胃康(%) | 25.83 | 16.85 | 12.31 |
| 头孢制剂系列(%) | 10.50 | 24.77 | 23.55 |
| 医疗服务费(%) | 19.16 | 17.49 | 13.37 |
| 原料药及中间体(%) | 13.67 | 15.46 | 19.83 |
| 医疗器械(%) | - | 0.00 | - |
| 其他(%) | 30.84 | 25.43 | 30.94 |
| 毛利构成(%) | |||
| 肠胃康(%) | 70.87 | 37.49 | 29.82 |
| 头孢制剂系列(%) | 1.38 | 36.06 | 43.19 |
| 医疗服务费(%) | 7.65 | 8.40 | 5.12 |
| 原料药及中间体(%) | 2.13 | 0.83 | 5.70 |
| 医疗器械(%) | - | 0.00 | - |
| 其他(%) | 17.97 | 17.22 | 16.17 |